Major Depressive Disorder

The study underscores the importance of interpreting patient-reported disease severity scores in the context of mental health factors.

Researchers find an increased risk of offspring ADHD symptoms due to maternal anxiety.

National survey data suggest that, well before COVID-19, the largest healthcare workforce in the US has been challenged by understaffing and stressful situations.

A longtime psychiatrist writes on a doctor's propensity for irritation, anxiety and self-medicating, and the work that goes into caring for colleagues.

Individuals diagnosed with mood or anxiety disorders were not linked to higher COVID-19 mortality.

These findings underscore the importance of safely implementing new marijuana legislation across the US.

Such scores could provide insight into the significant comorbidity rate of ADHD and other youth mood and emotional dysregulation issues.

When compared to standard care, a new CBT method results in a greater drop in SDQ Impact scores.

Despite these findings, there is still uncertainty as to whether mitigating symptoms of depression can lower cardiovascular risk.

Experts expect more individuals to face mental health challenges caused by the events of 2020.

The risk of suicidality and psychological adverse events appears to be particularly high in younger men with alopecia who are given finasteride.

Cataracts, but not AMD or glaucoma, were associated with an increased risk of depressive symptoms in the elderly in a prospective long-term study.

There was also a decline depression care in recent years among adolescents and young adults.

There could be a lasting impact caused by some of the changes due to the pandemic.

This edition from the 10 Year Plan features perspective from leadership at APA and AADPRT, as well as survey results from psychiatrists.

For many patients suffering from depression or anxiety, the added stress of the pandemic has led to a medication change.

J. John Mann, MD, discusses potential next steps for further assessment of ketamine's antidepressant effects.

J. John Mann, MD, discusses findings in a new study that uncovers the mechanisms behind Ketamine's antidepressant effect.

J. John Mann, MD, compares esketamine nasal spray to intravenous administration and explains the drawbacks of the newly approved treatment method for MDD.

The majority of older adults participating in the study expressed outrage at what they deemed to be an inadequate government response to the pandemic.

J. John Mann, MD, gives a brief overview of where we are now in treatment of major depressive disorder.

Low- and moderate-frequency magnetic seizure therapy help patients with treatment-resistant depression go into remission.

A number of new modifiable risk factors for depression were identified including confiding in others, time spent watching television, and daytime napping.

According to new findings, low Glx response is associated with increase in clinical improvements in at-need patients.

The risk of depression or clinically relevant depressive symptoms did not significantly differ between a group taking Vitamin D and a group taking a placebo.